More than half of U.S. nasal allergy sufferers report sleep issues as a result of their allergy symptoms, but 35 percent treat their symptoms, a survey says. The Asthma and Allergy Foundation of America and Teva Respiratory said the survey also found: -- 57 percent said they've experienced difficulty concentrating at work. -- 61 percent said they cannot enjoy the outdoors with their children as much as they would like due to their nasal allergies. -- 71 percent indicated they typically only treat their nasal allergies when they are experiencing symptoms or a flare-up. -- 48 percent said their nasal allergy symptoms, such as nasal congestion and sneezing, also interrupted their partner's sleep. "This survey further reinforces that although many people are significantly impacted by their nasal allergies, they are doing very little to avoid the onset of their burdensome symptoms," Bill McLin, president and of AAFA, said in a statement. The survey is part of Ditch the Drip: Get Serious about Nasal Allergies, an educational program featuring Misty May-Treanor, three-time Olympic beach volleyball gold medalist and nasal allergy sufferer. For the second year, May-Treanor will educate the 60 million Americans suffering from nasal allergies about the need for proactive preparation in advance of peak allergy seasons. The survey of 2,000 U.S. adults diagnosed with nasal allergies was conducted by Manhattan Research on behalf of Teva Respiratory. The margin of error was 2.2 percentage points.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor